Aatmaj Healthcare Limited (NSE:AATMAJ)
India · Delayed Price · Currency is INR 26.20
+1.50 (6.07%)
Nov 12, 2026, 3:29 PM IST
Aatmaj Healthcare Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 11, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 592 | 415 | 332 | 706 | - | - | |
Market Cap Growth | 27.80% | 24.83% | -52.96% | - | - | - |
Enterprise Value | 696 | 409 | 316 | 619 | - | - |
Last Close Price | 25.70 | 18.35 | 14.70 | 31.19 | - | - |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 11, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 105.54 | 58.14 | 51.97 | 80.18 | - | - |
PS Ratio | 1.94 | 1.71 | 1.70 | 4.49 | - | - |
PB Ratio | 1.16 | 0.82 | 0.66 | 1.43 | - | - |
P/TBV Ratio | 1.72 | 1.22 | 0.75 | 1.61 | - | - |
P/FCF Ratio | - | - | 12.79 | - | - | - |
P/OCF Ratio | 6.90 | 5.87 | 9.95 | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 11, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 2.28 | 1.68 | 1.62 | 3.93 | - | - |
EV/EBITDA Ratio | 26.38 | 17.35 | 19.35 | 23.62 | - | - |
EV/EBIT Ratio | 42.15 | 29.07 | 43.03 | 33.73 | - | - |
EV/FCF Ratio | - | - | 12.18 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 11, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.45 | 0.41 | 0.20 | 0.11 | 0.83 | 0.64 |
Debt / EBITDA Ratio | 8.78 | 8.91 | 6.16 | 2.09 | 1.19 | 0.69 |
Debt / FCF Ratio | - | - | 3.87 | - | 2.69 | - |
Net Debt / Equity Ratio | 0.20 | 0.18 | -0.04 | -0.11 | 0.80 | 0.62 |
Net Debt / EBITDA Ratio | 3.94 | 3.96 | -1.28 | -2.03 | 1.16 | 0.67 |
Net Debt / FCF Ratio | -2.53 | -1.71 | -0.81 | 0.34 | 2.62 | -5.85 |
Asset Turnover | 0.42 | 0.35 | 0.32 | 0.36 | 1.13 | - |
Inventory Turnover | - | 7.35 | 11.87 | 11.83 | 16.40 | - |
Quick Ratio | 2.10 | 2.25 | 3.44 | 5.13 | 1.26 | 0.68 |
Current Ratio | 2.90 | 2.90 | 4.24 | 6.43 | 1.38 | 0.79 |
Return on Equity (ROE) | 1.12% | 1.41% | 1.28% | 2.77% | 53.01% | - |
Return on Assets (ROA) | 1.43% | 1.26% | 0.76% | 2.58% | 23.78% | - |
Return on Invested Capital (ROIC) | 1.95% | 1.91% | 0.95% | 3.45% | 33.86% | 38.89% |
Return on Capital Employed (ROCE) | 2.60% | 2.30% | 1.40% | 3.60% | 55.10% | 74.80% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 11, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 0.95% | 1.72% | 1.92% | 1.25% | - | - |
FCF Yield | -6.92% | -13.19% | 7.82% | -22.40% | - | - |
Dividend Yield | - | - | - | 0.16% | - | - |
Buyback Yield / Dilution | -1.25% | - | - | -39.51% | -50.00% | - |
Total Shareholder Return | -1.25% | - | - | -39.35% | -50.00% | - |